White Paper: AI-Digital-Physical Convergence: The Future of DMTA in Drug Discovery & Development

[Article Title]

This paper explores the convergence of physical experimentation with software and AI applications to accelerate DMTA cycles in pharmaceutical R&D.

Covering both discovery and CMC development, the paper discusses how automation and digitalization with scientific informatics tools can minimize or eliminate manual data transfer for robust experiment cycles with greater data integrity and higher productivity.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.